After opening the day on a negative note, Indian share market reversed the trend as session progressed and ended the day higher.
Benchmark indices were muted on Tuesday as some domestic buying helped limit losses from relentless selling by foreign funds over fears that global interest rates will stay higher for longer.
At the closing bell on Friday, the BSE Sensex stood 173 points higher (up 0.3%).
Meanwhile, the NSE Nifty closed 51 points higher (up 0.3%).
ITC and Cipla were among the top gainers today.
Titan and BPCL on the other hand, were among the top losers today.
The GIFT Nifty was trading at 19,826, up by 94 points, at the time of writing.
The BSE Mid Cap index and the BSE Small Cap index ended 0.7% higher.
Sectoral indices ended mixed, with stocks in the healthcare sector and FMCG sector witnessing buying. Meanwhile stocks in the oil and gas sector and banking sector witnessed selling.
Shares of REC and TVS Motors hit their 52-week high today.
The rupee is trading at Rs 83.22 against the US dollar.
Asia-Pacific markets ended on a positive note.
The Nikkei index ended 0.2% higher, Hang Seng index ended 0.8% higher, while the Shanghai Composite ended 0.2% higher.
In commodity markets, gold prices are trading 0.4% at Rs 58,229 per 10 grams today.
Meanwhile, silver prices are trading 0.6% lower at Rs 71,352 per 1 kg.
Now track the biggest movers of the stock market using stocks to watch today section. This should help you keep updated with the latest developments...
Speaking of stock markets, when it rains, it pours.
If you don't believe in this phrase, just ask the Delta Corp management. They will tell you from their first-hand experience that the phrase is pretty much valid and can make life very, very difficult.
Talking of a difficult life, the share price performance of Delta Corp Ltd has certainly made the life very difficult for its investors and management alike.
What now though? Is the risk-reward equation in favour of investors or is there very high unpredictability?
In the below video, Cohead of research, Rahul Shah answers all this in the video below.
In news from textile sector, Aditya Birla Fashion & Retail (ABFRL) has completed the acquisition of a 51% stake in TCNS Clothing to become a promoter of the women's apparel brand.
TCNS has become a subsidiary of the company and will also be a material subsidiary of the company by SEBI Listing Regulations.
On 5 May Aditya Birla Group announced that it will acquire a majority stake in TCNS Clothing, in a deal worth Rs 16.5 bn.
As per the deal, it acquired TCNS Clothing's founding promoter's stake through a SPA (Share Purchase Agreement), followed by an open offer.
As per SPA, ABFRL acquired a total of 14.1 equity shares constituting 22% of the expanded share capital of the company.
Aditya Birla Fashion & Retail is one of the Top 5 Stocks to Benefit from this Upcoming Festive Season.
Moving on to news from the pharma sector, Sun Pharma on Wednesday announced that PRWINLEVI is now available in Canada.
According to the company's press statement, WINLEVI is the first and only androgen receptor inhibitor indicated for the topical treatment of acne vulgaris (acne) in patients 12 years of age and older.
Instead of a topical approach to acne treatment that focuses on follicular hyperkeratinisation, reducing inflammation or exerting antibacterial effects, WINLEVI is thought to reduce the effects of acne hormones on the skin by disrupting the androgen cascade.
While the exact way that WINLEVI works is unknown, it aims to inhibit the effects of androgen receptors in cells of the sebaceous glands (oil-producing glands in the skin) to help reduce sebum (oil) production and inflammatory cytokines.
Sun Pharma is the fourth largest specialty generic pharmaceutical company in the world.
Among the top global pharmaceutical giants, Sun Pharma is the ninth largest pharma company in the USA generic medications market and second in the dermatology segment.
It is among 4 Pharma Stocks to Watch Out for Potential Multibagger Returns.
Moving on to news from the pharma sector, shares of Suzlon Energy opened 3% lower on 27 September after Sun Pharma promoter Dilip Shanghvi and his associate companies decided to terminate the amended and restated shareholders' agreement.
Following the termination of the agreement, the investor group's nominee director on Suzlon's board, Hiten Timbadia has also resigned with effect from 26 September.
However, the wind turbine manufacturer has clarified that the termination of the agreement will not affect the company's operations.
Dilip Shanghvi also issued a separate statement, indicating that although the formal shareholder agreement has been cancelled, he and his affiliated firms will remain investors in the company.
According to shareholding data at the end of the June quarter, Dilip Shanghvi and his associate companies collectively held at least a 7.4% stake in Suzlon.
Shanghvi's statement also expressed support for Suzlon's ambitious growth plans and their efforts to recapture market share.
Suzlon is a renewable energy solutions provider. The company is involved in the business of manufacturing, project execution and operation and maintenance of wind turbine generators and sale of related components.
To know whether the multibagger journey of Suzlon Energy run its course, check out Suzlon Energy: A Trap or a Big Wealth Creation Opportunity.
To know what's moving the Indian stock markets today, check out the most recent share market updates here.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
Equitymaster requests your view! Post a comment on "Sensex Today Ends 173 Points Higher | REC Jumps 6% | ITC & Cipla Top Gainers". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!